Noninvasive Measurements of Glycogen in Perfused Mouse Livers Using Chemical Exchange Saturation Transfer NMR and Comparison to 13C NMR Spectroscopy
Open Access
- 6 May 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 87 (11) , 5824-5830
Abstract
Liver glycogen represents an important physiological form of energy storage. It plays a key role in the regulation of blood glucose concentrations, and dysregulations in hepatic glycogen metabolism are linked to many diseases including diabetes and insulin resistance. In this work, we develop, optimize, and validate a noninvasive protocol to measure glycogen levels in isolated perfused mouse livers using chemical exchange saturation transfer (CEST) NMR spectroscopy. Model glycogen solutions were used to determine optimal saturation pulse parameters which were then applied to intact perfused mouse livers of varying glycogen content. Glycogen measurements from serially acquired CEST Z-spectra of livers were compared with measurements from interleaved natural abundance 13C NMR spectra. Experimental data revealed that CEST-based glycogen measurements were highly correlated with 13C NMR glycogen spectra. Monte Carlo simulations were then used to investigate the inherent (i.e., signal-to-noise-based) errors in the quantification of glycogen with each technique. This revealed that CEST was intrinsically more precise than 13C NMR, although in practice may be prone to other errors induced by variations in experimental conditions. We also observed that the CEST signal from glycogen in liver was significantly less than that observed from identical amounts in solution. Our results demonstrate that CEST provides an accurate, precise, and readily accessible method to noninvasively measure liver glycogen levels and their changes. Furthermore, this technique can be used to map glycogen distributions via conventional proton magnetic resonance imaging, a capability universally available on clinical and preclinical magnetic resonance imaging (MRI) scanners vs 13C detection, which is limited to a small fraction of clinical-scale MRI scanners.Keywords
This publication has 24 references indexed in Scilit:
- Regulation of Hepatic Glucose Uptake and Storage In VivoAdvances in Nutrition, 2012
- Pompe Disease: A Review of the Current Diagnosis and Treatment Recommendations in the Era of Enzyme Replacement TherapyJournal of Clinical Neuromuscular Disease, 2008
- The Variable Presentations of Glycogen Storage Disease Type IV: A Review of Clinical, Enzymatic and Molecular StudiesCurrent Molecular Medicine, 2002
- Diabetes mellitus secondary to glycogen storage disease type IIIDiabetic Medicine, 2000
- Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.Journal of Clinical Investigation, 1996
- Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.Journal of Clinical Investigation, 1995
- Sources of carbon for hepatic glycogen synthesis in the conscious dog.Journal of Clinical Investigation, 1991
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- Detection of human muscle glycogen by natural abundance 13C NMR.Proceedings of the National Academy of Sciences, 1988
- Natural abundance 13C NMR spectrum of glycogen in humansMagnetic Resonance in Medicine, 1987